Molekulare Therapie neuroendokriner Neoplasien: Sunitinib (Sutent) und Everolimus (Afinetor).

  • Dieter Hörsch
  • Jörg Schrader

Related Research units

Bibliographical data

Original languageGerman
Publication statusPublished - 2014